124 related articles for article (PubMed ID: 21801387)
1. Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study.
Knudsen EC; Seljeflot I; Abdelnoor M; Eritsland J; Mangschau A; Müller C; Arnesen H; Andersen GO
BMC Endocr Disord; 2011 Jul; 11():14. PubMed ID: 21801387
[TBL] [Abstract][Full Text] [Related]
2. Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients.
Knudsen EC; Seljeflot I; Abdelnoor M; Eritsland J; Mangschau A; Arnesen H; Andersen GO
Cardiovasc Diabetol; 2009 Jan; 8():6. PubMed ID: 19183453
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of CRP and MCP-1 are associated with previously unknown abnormal glucose regulation in patients with acute STEMI: a cohort study.
Knudsen EC; Seljeflot I; Michael A; Eritsland J; Mangschau A; Müller C; Arnesen H; Andersen GØ
Cardiovasc Diabetol; 2010 Sep; 9():47. PubMed ID: 20809989
[TBL] [Abstract][Full Text] [Related]
4. Glucose associated NETosis in patients with ST-elevation myocardial infarction: an observational study.
Helseth R; Knudsen EC; Eritsland J; Opstad TB; Arnesen H; Andersen GØ; Seljeflot I
BMC Cardiovasc Disord; 2019 Oct; 19(1):221. PubMed ID: 31615411
[TBL] [Abstract][Full Text] [Related]
5. Does heart rate variability correlate with long-term prognosis in myocardial infarction patients treated by early revascularization?
Compostella L; Lakusic N; Compostella C; Truong LV; Iliceto S; Bellotto F
World J Cardiol; 2017 Jan; 9(1):27-38. PubMed ID: 28163834
[TBL] [Abstract][Full Text] [Related]
6. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction.
Bartnik M; Malmberg K; Norhammar A; Tenerz A; Ohrvik J; Rydén L
Eur Heart J; 2004 Nov; 25(22):1990-7. PubMed ID: 15541834
[TBL] [Abstract][Full Text] [Related]
7. Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.
Holman RR; Coleman RL; Chan JCN; Chiasson JL; Feng H; Ge J; Gerstein HC; Gray R; Huo Y; Lang Z; McMurray JJ; Rydén L; Schröder S; Sun Y; Theodorakis MJ; Tendera M; Tucker L; Tuomilehto J; Wei Y; Yang W; Wang D; Hu D; Pan C;
Lancet Diabetes Endocrinol; 2017 Nov; 5(11):877-886. PubMed ID: 28917545
[TBL] [Abstract][Full Text] [Related]
8. Newly diagnosed glucose intolerance and prognosis after acute myocardial infarction: comparison of post-challenge versus fasting glucose concentrations.
Tamita K; Katayama M; Takagi T; Yamamuro A; Kaji S; Yoshikawa J; Furukawa Y
Heart; 2012 Jun; 98(11):848-54. PubMed ID: 22581733
[TBL] [Abstract][Full Text] [Related]
9. [Prevalence of glucometabolic abnormalities in connection with myocardial infarction in a Danish coronary care unit].
Egstrup M; Henriksen FL; Høfsten DE; Jensen BK; Hangaard J; Egstrup K
Ugeskr Laeger; 2008 Mar; 170(11):942-6. PubMed ID: 18397622
[TBL] [Abstract][Full Text] [Related]
10. Impaired Glucose Tolerance or Newly Diagnosed Diabetes Mellitus Diagnosed during Admission Adversely Affects Prognosis after Myocardial Infarction: An Observational Study.
George A; Bhatia RT; Buchanan GL; Whiteside A; Moisey RS; Beer SF; Chattopadhyay S; Sathyapalan T; John J
PLoS One; 2015; 10(11):e0142045. PubMed ID: 26571120
[TBL] [Abstract][Full Text] [Related]
11. [Abnormal glucose tolerance and long-term prognosis in patients with acute myocardial infarction].
David LA; Grosu AA
Kardiologiia; 2013; 53(9):15-20. PubMed ID: 24090381
[TBL] [Abstract][Full Text] [Related]
12. IgM antibodies against phosphorylcholine measured early after acute ST-elevation myocardial infarction in relation to atherosclerotic disease burden and long-term clinical outcome.
Knudsen EC; Seljeflot I; Aksnes TA; Eritsland J; Arnesen H; Andersen GØ
PLoS One; 2019; 14(4):e0215640. PubMed ID: 31002684
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of admission mean platelet volume to platelet count ratio in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Bolat I; Akgul O; Cakmak HA; Pusuroglu H; Somuncu U; Ozbey S; Ornek V; Erturk M; Gul M
Kardiol Pol; 2016; 74(4):346-55. PubMed ID: 26365942
[TBL] [Abstract][Full Text] [Related]
14. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes.
Vis MM; Sjauw KD; van der Schaaf RJ; Baan J; Koch KT; DeVries JH; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
Am Heart J; 2007 Dec; 154(6):1184-90. PubMed ID: 18035093
[TBL] [Abstract][Full Text] [Related]
15. Dysglycemia and increased left ventricle mass in normotensive patients admitted with a first myocardial infarction: prognostic implications of dysglycemia during 14 years of follow-up.
Pararajasingam G; Løgstrup BB; Høfsten DE; Christophersen TB; Auscher S; Hangaard J; Egstrup K
BMC Cardiovasc Disord; 2019 May; 19(1):103. PubMed ID: 31046690
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
17. Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention.
Pres D; Gasior M; Strojek K; Gierlotka M; Hawranek M; Lekston A; Wilczek K; Tajstra M; Gumprecht J; Poloński L
Kardiol Pol; 2010 Jul; 68(7):743-51. PubMed ID: 20648428
[TBL] [Abstract][Full Text] [Related]
18. Sustained prognostic implications of newly detected glucose abnormalities in patients with acute myocardial infarction: long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort.
Ritsinger V; Tanoglidi E; Malmberg K; Näsman P; Rydén L; Tenerz Å; Norhammar A
Diab Vasc Dis Res; 2015 Jan; 12(1):23-32. PubMed ID: 25311248
[TBL] [Abstract][Full Text] [Related]
19. The risk of diabetes development in long-term observation of patients with acute hyperglycaemia during myocardial infarction.
Terlecki M; Bryniarski L; Bednarek A; Kocowska M; Kawecka-Jaszcz K; Czarnecka D
Kardiol Pol; 2015; 73(8):606-12. PubMed ID: 26310364
[TBL] [Abstract][Full Text] [Related]
20. Impact of newly diagnosed abnormal glucose tolerance on long-term prognosis in patients with acute myocardial infarction.
Tamita K; Katayama M; Takagi T; Akasaka T; Yamamuro A; Kaji S; Morioka S; Kihara Y
Circ J; 2007 Jun; 71(6):834-41. PubMed ID: 17526977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
